Enterprise Value
3.759B
Cash
262.4M
Avg Qtr Burn
-52.95M
Short % of Float
7.48%
Insider Ownership
1.93%
Institutional Own.
87.15%
Qtr Updated
12/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|